These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. A new in vivo model to test anti-tuberculosis drugs using fluorescence imaging. Zelmer A; Carroll P; Andreu N; Hagens K; Mahlo J; Redinger N; Robertson BD; Wiles S; Ward TH; Parish T; Ripoll J; Bancroft GJ; Schaible UE J Antimicrob Chemother; 2012 Aug; 67(8):1948-60. PubMed ID: 22635525 [TBL] [Abstract][Full Text] [Related]
10. Rapid point-of-care detection of the tuberculosis pathogen using a BlaC-specific fluorogenic probe. Xie H; Mire J; Kong Y; Chang M; Hassounah HA; Thornton CN; Sacchettini JC; Cirillo JD; Rao J Nat Chem; 2012 Oct; 4(10):802-9. PubMed ID: 23000993 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of liquid culture for quantitation of Mycobacterium tuberculosis in murine models. O'Sullivan DM; Sander C; Shorten RJ; Gillespie SH; Hill AV; McHugh TD; McShane H; Tchilian EZ Vaccine; 2007 Nov; 25(49):8203-5. PubMed ID: 17980937 [TBL] [Abstract][Full Text] [Related]
12. A lung-on-chip model of early Thacker VV; Dhar N; Sharma K; Barrile R; Karalis K; McKinney JD Elife; 2020 Nov; 9():. PubMed ID: 33228849 [TBL] [Abstract][Full Text] [Related]
13. Effect of the bradykinin 1 receptor antagonist SSR240612 after oral administration in Mycobacterium tuberculosis-infected mice. Rodrigues-Junior VS; Pail PB; Villela AD; Falcão VCA; Dadda AS; Abbadi BL; Pesquero JB; Santos DS; Basso LA; Campos MM Tuberculosis (Edinb); 2018 Mar; 109():1-7. PubMed ID: 29559112 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of Mycobacterium tuberculosis glutamine synthetase as a novel antibiotic strategy against tuberculosis: demonstration of efficacy in vivo. Harth G; Horwitz MA Infect Immun; 2003 Jan; 71(1):456-64. PubMed ID: 12496196 [TBL] [Abstract][Full Text] [Related]
15. [A study of beta-lactamase activity of mycobacteria and clinical trial of penicillin/beta-lactamase inhibitor combinations in the treatment of drug-resistant Mycobacterium tuberculosis]. Nakagawa Y; Shimazu K; Ebihara M; Aman K Kekkaku; 1999 May; 74(5):447-52. PubMed ID: 10386034 [TBL] [Abstract][Full Text] [Related]
16. [Recent progress in mycobacteriology]. Okada M; Kobayashi K Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602 [TBL] [Abstract][Full Text] [Related]
17. First clinical assessment of a prototype assay to detect the enzymatic activity of β-lactamase as a marker for pulmonary tuberculosis. Nabeta P; Seshadri P; Havumaki J; Mbhele S; Hendricks L; Perkins MD; Nicol MP; Denkinger CM Diagn Microbiol Infect Dis; 2020 Jun; 97(2):115026. PubMed ID: 32173144 [TBL] [Abstract][Full Text] [Related]
18. Inactivation of the ilvB1 gene in Mycobacterium tuberculosis leads to branched-chain amino acid auxotrophy and attenuation of virulence in mice. Awasthy D; Gaonkar S; Shandil RK; Yadav R; Bharath S; Marcel N; Subbulakshmi V; Sharma U Microbiology (Reading); 2009 Sep; 155(Pt 9):2978-2987. PubMed ID: 19542000 [TBL] [Abstract][Full Text] [Related]
19. False-positive Gen-Probe direct Mycobacterium tuberculosis amplification test results for patients with pulmonary M. kansasii and M. avium infections. Jorgensen JH; Salinas JR; Paxson R; Magnon K; Patterson JE; Patterson TF J Clin Microbiol; 1999 Jan; 37(1):175-8. PubMed ID: 9854086 [TBL] [Abstract][Full Text] [Related]